Boris Bartholdy

7PUBLICATIONS
53CO-AUTHORS
Medical infection agents (incl. prions)Disease surveillanceGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2022
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.

Ujunwa Cynthia Okoye-Okafor, Komal K Javarappa, Dimitrios Tsallos

|Jul 12, 2022
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation.

Maria M Aivalioti, Boris A Bartholdy, Kith Pradhan

|Jul 03, 2021
<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.

Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska

|Feb 09, 2020
The Golgi Glycoprotein MGAT4D is an Intrinsic Protector of Testicular Germ Cells From Mild Heat Stress.

Ayodele Akintayo, Meng Liang, Boris Bartholdy

|Jun 01, 2019
Proteome-wide analysis of chaperone-mediated autophagy targeting motifs.

Philipp Kirchner, Mathieu Bourdenx, Julio Madrigal-Matute

|Mar 14, 2019
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.

Elaine Y Chung, Yun Mai, Urvi A Shah

Pageof 2